IDEXX Laboratories Inc. Common Stock (IDXX)

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematolo…

Sector

Health Care

Industry

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Employees

11,000

Website

www.idexx.com/

Fundamentals

1-day range

$545.48$556.01

Market cap

$46.48B

P/E (trailing)

39.00

P/E (forward)

33.15

EPS (trailing)

$14.23

Dividend yield

—

Beta

1.55

Avg. volume

629.9K

Forecasts

13 analyst ratings

IDEXX Laboratories Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• IDXX

  IDEXX Laboratories Inc. Common Stock

  $554.92

  ▲ 1.81%
  Market cap $46.48BP/E 39.00
  $518.55$769.98
• ORKA

  Oruka Therapeutics Inc. Common Stock

  $91.07

  ▼ 5.67%
  Market cap $5.94BP/E —
  $14.61$115.52
• NEOG

  Neogen Corporation Common Stock

  $11.67

  ▼ 0.60%
  Market cap $2.46BP/E —
  $4.9$12.85
• NTLA

  Intellia Therapeutics Inc. Common Stock

  $12.87

  ▼ 1.83%
  Market cap $1.57BP/E —
  $7.95$28.25
• NNNN

  Anbio Biotechnology Class A Ordinary Shares

  $7.64

  ▼ 1.80%
  Market cap $1.40BP/E 144.72
  $6.61$51.33
• ACHV

  Achieve Life Sciences Inc. Common Shares

  $8.09

  ▼ 1.16%
  Market cap $672.42MP/E —
  $2.62$8.61
• TKNO

  Alpha Teknova Inc. Common Stock

  $7.13

  ▼ 2.46%
  Market cap $350.10MP/E —
  $1.91$7.84

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Insider Decision: Andrew Emerson Exercises Options At IDEXX Laboratories For $101K
  Benzinga · 8/25/2026
• Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?
  Yahoo · 8/21/2026
• Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding
  Yahoo · 8/20/2026
• IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve
  Yahoo · 8/20/2026
• Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
  Yahoo · 8/19/2026
• IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day Transcript
  SeekingAlpha · 8/18/2026
• IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution
  SeekingAlpha · 8/18/2026
• Zoetis: A Solid Long-Term Buy After Harsh Drawdown
  SeekingAlpha · 8/18/2026
• Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $710
  benzinga · 8/11/2026

• Andrew Emerson · August 20, 2026 · Option Exercise

  265 @ $178.26
• Andrew Emerson · August 20, 2026 · Tax Withholding

  86
• Joseph L. Hooley · July 30, 2026 · Grant

  49 @ $558.8
• George Fennell · June 1, 2026 · Option Exercise

  639
• George Fennell · June 1, 2026 · Tax Withholding

  284 @ $566.79
• Karen Peacock · May 12, 2026 · Grant

  234
• Karen Peacock · May 12, 2026 · Grant

  525
• Sam Samad · May 12, 2026 · Grant

  234
• Sam Samad · May 12, 2026 · Grant

  525
• Irene Chang Britt · May 12, 2026 · Grant

  234
• Irene Chang Britt · May 12, 2026 · Grant

  525
• Sophie Vandebroek V · May 12, 2026 · Grant

  234
• Sophie Vandebroek V · May 12, 2026 · Grant

  525
• Claflin Bruce L. · May 12, 2026 · Grant

  234
• Claflin Bruce L. · May 12, 2026 · Grant

  525

Institutional Ownership

March 31, 2026

Total shares held

65.59M

Total value held

$35.61B

Institutional holders

1285